Robert J. Hariri - Feb 16, 2024 Form 4 Insider Report for Celularity Inc (CELU)

Role
Chief Executive Officer, Director
Signature
/s/ Kyle Fletcher, Attorney-in-Fact
Stock symbol
CELU
Transactions as of
Feb 16, 2024
Transactions value $
$0
Form type
4
Date filed
2/21/2024, 09:46 PM
Previous filing
Dec 18, 2023
Next filing
Apr 16, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CELU Stock Option Grant (Right to Buy) Award $0 +2.94M $0.00 2.94M Feb 16, 2024 Class A Common Stock 2.94M $0.43 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted pursuant to the Issuer's 2021 Equity Incentive Plan. The shares underlying such option will vest in equal quarterly installments during 2024 such that 25% of the option will vest on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024, subject to the Reporting Person's continuous service with the Issuer through each such date.